查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1951909

次世代定序资料分析市场分析及预测（至2035年）：按类型、产品、服务、技术、组件、应用、最终用户和解决方案划分

Next generation Sequencing Data Analysis Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Solutions
出版日期: | 出版商: Global Insight Services | 英文 349 Pages | 商品交期: 3-5个工作天内

价格
简介目录

次世代定序资料分析市场预计将从2024年的8.129亿美元成长到2034年的64.1亿美元，复合年增长率约为24.5%。次世代定序数据的解决方案和服务，这对于个人化医疗和生物技术至关重要。这些解决方案和服务包括生物资讯学工具、云端运算和人工智慧驱动的分析，有助于快速且准确地洞察基因变异。市场成长的驱动力主要来自于定序技术的进步及其在临床诊断和研究领域不断扩展的应用。

次世代定序资料分析市场预计将稳定成长，这主要得益于基因组研究和个人化医疗的进步。软体领域主导，生物资讯工具和资料解读平台在其中发挥关键作用，它们在将原始资料转化为可操作的洞见方面发挥着重要作用。在该领域中，变异检测工具和基因组註释工具表现尤为出色，它们对于识别基因变异和功能元件至关重要。服务领域紧随其后，这主要得益于数据分析外包给专业服务提供者的趋势日益增长。在服务领域，资料管理和储存解决方案的重要性日益凸显，以满足对高效处理海量基因组资料集的日益增长的需求。儘管云端平台因其扩充性和成本效益而越来越受欢迎，但对于优先考虑资料安全的机构而言，本地部署解决方案仍然至关重要。此外，科技公司与研究机构之间的合作正在推动市场发展，促进创新并提升分析能力。人工智慧 (AI) 和机器学习的融合有望透过优化数据处理和预测分析来推动未来的成长。

市场区隔
类型 全基因组定序、EXOME定序、标靶定序、RNA定序、表观基因学、宏总体基因体学、从头定序、单细胞定序
产品 软体、平台、试剂盒和试剂、耗材
服务 数据分析、数据管理、数据解读与咨询服务
科技 合成定定序、离子半导体定序、焦磷酸测序、单分子即时定序、奈米孔定序
成分 硬体、软体和服务
目的 临床诊断、药物研发、农业与动物研究、生物标记发现、法医学
最终用户 学术研究机构、製药和生物技术公司、医院和诊所、诊断检查室
解决方案 本机部署、云端部署、混合式部署

次世代定序资料分析市场持续稳定成长，提供创新解决方案的公司占据了显着的市场份额。定价策略竞争激烈，反映出市场对先进定序技术的需求日益增长。频繁的新产品发布凸显了该市场的活力。各公司正致力于提高数据的准确性和速度，这对于保持竞争优势至关重要。云端解决方案的采用尤其值得关注，因为它们提供了扩充性和柔软性。北美继续保持主导地位，而亚太地区则在技术进步和日益活跃的研究活动的推动下，展现出令人瞩目的投资趋势。次世代定序资料分析市场的竞争异常激烈，主要参与者不断评估竞争对手的状况。监管的影响在北美和欧洲尤为显着，严格的指导方针影响市场动态。遵守这些法规对于市场准入和永续性至关重要。各公司正利用策略联盟和收购来巩固其市场地位。这个市场的特点是技术快速发展，这既带来了机会，也带来了挑战。虽然人工智慧 (AI) 和机器学习的整合有望推动创新，但监管障碍和资料隐私问题仍然是重大挑战。

主要趋势和驱动因素：

次世代定序(NGS) 资料分析市场正经历强劲成长，这主要得益于技术进步和定序方案的日益普及，这些解决方案能够实现扩充性、柔软性且协作式的数据分析。对于寻求有效管理海量资料集的研究机构和生物技术公司而言，这些解决方案尤其具有吸引力。此外，个人化医疗的兴起也推动了对 NGS 数据分析的需求，因为它能够基于个别基因谱制定治疗方案。监管支持和政府资助也是关键驱动因素，它们促进了基因组研究和开发。这些努力促进了创新并拓展了市场机会。此外，慢性病盛行率的不断上升也需要更先进的基因组研究，进一步加速了市场成长。能够提供全面且易于使用的分析平台的公司将占据有利地位，从而掌握这一蓬勃发展的机会。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 全基因组定序
    • EXOME定序
    • 标靶定序
    • RNA定序
    • 表观基因
    • 总体基因体学
    • 从头测序
    • 单细胞定序
  • 市场规模及预测：依产品划分
    • 软体
    • 平台
    • 试剂盒和试剂
    • 消耗品
  • 市场规模及预测：依服务划分
    • 数据分析
    • 资料管理
    • 数据解读
    • 咨询服务
  • 市场规模及预测：依技术划分
    • 合成定定序
    • 离子半导体定序
    • 焦磷酸测序
    • 单分子即时定序
    • 奈米孔定序
  • 市场规模及预测：依组件划分
    • 硬体
    • 软体
    • 服务
  • 市场规模及预测：依应用领域划分
    • 临床诊断
    • 药物发现
    • 农业/动物研究
    • 生物标记发现
    • 法医学
  • 市场规模及预测：依最终用户划分
    • 学术研究机构
    • 製药和生物技术公司
    • 医院和诊所
    • 诊断检查室
  • 市场规模及预测：按解决方案划分
    • 本地部署
    • 基于云端的
    • 杂交种

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 其他亚太地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • Illumina
  • Qiagen
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • BGI Genomics
  • Roche Sequencing Solutions
  • Genomatix
  • DNASTAR
  • Partek Incorporated
  • Seven Bridges Genomics
  • Genalice
  • Golden Helix
  • Biomatters
  • Geno Logics
  • CLC bio
  • DNAnexus
  • Congenica
  • Fabric Genomics

第九章：关于我们

简介目录
Product Code: GIS21359

Next generation Sequencing Data Analysis Market is anticipated to expand from $812.9 million in 2024 to $6,410.0 million by 2034, growing at a CAGR of approximately 24.5%. The Next Generation Sequencing Data Analysis Market encompasses solutions and services for interpreting complex genomic data, pivotal for personalized medicine and biotechnology. It involves bioinformatics tools, cloud computing, and AI-driven analytics, facilitating rapid and accurate insights into genetic variations. The market's growth is propelled by advancements in sequencing technologies and increasing applications in clinical diagnostics and research.

The Next Generation Sequencing Data Analysis Market is poised for robust expansion, driven by advancements in genomic research and personalized medicine. The software segment dominates, with bioinformatics tools and data interpretation platforms leading due to their critical role in translating raw data into actionable insights. Within this segment, variant calling and genome annotation tools are top performers, essential for identifying genetic variations and functional elements. The services segment follows, propelled by the increasing outsourcing of data analysis to specialized providers. Within services, data management and storage solutions are gaining prominence, addressing the growing need for efficient handling of vast genomic datasets. Cloud-based platforms are becoming increasingly popular, offering scalability and cost-effectiveness, while on-premise solutions continue to be significant for institutions prioritizing data security. The market is further bolstered by collaborations between technology companies and research institutions, fostering innovation and enhancing analytical capabilities. The integration of artificial intelligence and machine learning is expected to drive future growth, optimizing data processing and predictive analytics.

Market Segmentation
TypeWhole Genome Sequencing, Exome Sequencing, Targeted Sequencing, RNA Sequencing, Epigenomics, Metagenomics, De Novo Sequencing, Single-cell Sequencing
ProductSoftware, Platforms, Kits and Reagents, Consumables
ServicesData Analysis, Data Management, Data Interpretation, Consulting Services
TechnologySequencing by Synthesis, Ion Semiconductor Sequencing, Pyrosequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing
ComponentHardware, Software, Services
ApplicationClinical Diagnosis, Drug Discovery, Agricultural and Animal Research, Biomarker Discovery, Forensic Science
End UserAcademic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Diagnostic Laboratories
SolutionsOn-premise, Cloud-based, Hybrid

The Next Generation Sequencing Data Analysis Market is experiencing robust growth, with significant market share held by companies offering innovative solutions. Pricing strategies are competitive, reflecting the increasing demand for advanced sequencing technologies. New product launches are frequent, underscoring the dynamic nature of this market. Companies are focusing on enhancing data accuracy and speed, which is crucial for maintaining a competitive edge. The adoption of cloud-based solutions is particularly noteworthy, as it offers scalability and flexibility. North America remains a leader, while the Asia-Pacific region shows promising investment trends, driven by technological advancements and increased research activities. Competition in the Next Generation Sequencing Data Analysis Market is intense, with key players continuously benchmarking their offerings against competitors. Regulatory influences are significant, particularly in North America and Europe, where stringent guidelines impact market dynamics. Compliance with these regulations is essential for market entry and sustainability. Companies are leveraging strategic partnerships and acquisitions to strengthen their market positions. The market is characterized by rapid technological advancements, which present both opportunities and challenges. The integration of artificial intelligence and machine learning is expected to drive innovation, while regulatory hurdles and data privacy concerns remain critical issues to address.

Geographical Overview:

The Next Generation Sequencing (NGS) Data Analysis Market is witnessing robust growth across multiple regions, each exhibiting unique characteristics. North America leads the market, propelled by advanced healthcare infrastructure and significant investments in genomic research. The region's strong focus on precision medicine and personalized healthcare further accelerates market expansion. Europe follows, with substantial government funding and a well-established research ecosystem driving NGS adoption. The region's stringent regulatory frameworks ensure data quality and security, enhancing market credibility. In the Asia Pacific, rapid technological advancements and increasing healthcare expenditure are key growth drivers. Countries like China and India are emerging as significant players, investing heavily in genomic research and bioinformatics. Latin America and the Middle East & Africa present burgeoning opportunities. In Latin America, rising awareness of genomics and improved healthcare access are catalysts for growth. The Middle East & Africa are investing in healthcare modernization, recognizing NGS's potential in advancing medical research and diagnostics.

The Next Generation Sequencing Data Analysis Market is profoundly influenced by global tariff policies, geopolitical dynamics, and evolving supply chain strategies. In Japan and South Korea, heightened trade tensions with the US are prompting a strategic pivot toward domestic innovation in sequencing technologies to mitigate tariff-induced costs. China's focus on self-reliance is accelerating its investment in indigenous sequencing solutions amidst export restrictions. Taiwan, while a pivotal player in semiconductor manufacturing, faces geopolitical vulnerabilities that could impact its market stability. Globally, the parent market shows robust growth, driven by advancements in personalized medicine and genomics. By 2035, market evolution will hinge on resilient supply chains and strategic partnerships. Meanwhile, Middle East conflicts pose risks to energy prices, potentially affecting operational costs and timelines across the sector.

Key Trends and Drivers:

The Next Generation Sequencing (NGS) Data Analysis Market is experiencing robust growth, driven by technological advancements and decreasing sequencing costs. A key trend is the integration of artificial intelligence and machine learning, which is enhancing data interpretation accuracy and efficiency. This integration is enabling researchers to derive more meaningful insights from complex genomic data. Another significant trend is the increasing adoption of cloud-based solutions, which facilitate scalable, flexible, and collaborative data analysis. These solutions are particularly appealing to research institutions and biotech companies looking to manage vast datasets effectively. Furthermore, the rise of personalized medicine is propelling demand for NGS data analysis, as it allows for tailored therapeutic approaches based on individual genetic profiles. Regulatory support and government funding are also pivotal drivers, encouraging research and development in genomics. These initiatives are fostering innovation and expanding market opportunities. Additionally, the growing prevalence of chronic diseases is necessitating advanced genomic research, further fueling market growth. Companies that can offer comprehensive, user-friendly analysis platforms are poised to capitalize on these burgeoning opportunities.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Whole Genome Sequencing
    • 4.1.2 Exome Sequencing
    • 4.1.3 Targeted Sequencing
    • 4.1.4 RNA Sequencing
    • 4.1.5 Epigenomics
    • 4.1.6 Metagenomics
    • 4.1.7 De Novo Sequencing
    • 4.1.8 Single-cell Sequencing
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Software
    • 4.2.2 Platforms
    • 4.2.3 Kits and Reagents
    • 4.2.4 Consumables
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Data Analysis
    • 4.3.2 Data Management
    • 4.3.3 Data Interpretation
    • 4.3.4 Consulting Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Sequencing by Synthesis
    • 4.4.2 Ion Semiconductor Sequencing
    • 4.4.3 Pyrosequencing
    • 4.4.4 Single-molecule Real-time Sequencing
    • 4.4.5 Nanopore Sequencing
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Hardware
    • 4.5.2 Software
    • 4.5.3 Services
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Clinical Diagnosis
    • 4.6.2 Drug Discovery
    • 4.6.3 Agricultural and Animal Research
    • 4.6.4 Biomarker Discovery
    • 4.6.5 Forensic Science
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Academic and Research Institutes
    • 4.7.2 Pharmaceutical and Biotechnology Companies
    • 4.7.3 Hospitals and Clinics
    • 4.7.4 Diagnostic Laboratories
  • 4.8 Market Size & Forecast by Solutions (2020-2035)
    • 4.8.1 On-premise
    • 4.8.2 Cloud-based
    • 4.8.3 Hybrid

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Illumina
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Qiagen
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Thermo Fisher Scientific
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Agilent Technologies
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Oxford Nanopore Technologies
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Pacific Biosciences
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 BGI Genomics
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Roche Sequencing Solutions
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Genomatix
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 DNASTAR
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Partek Incorporated
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Seven Bridges Genomics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Genalice
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Golden Helix
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Biomatters
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Geno Logics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 CLC bio
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 DNAnexus
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Congenica
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Fabric Genomics
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us